Producer
Jungbunzlauer Suisse AG
Swiss specialty fermentation chemicals company (HQ Basel; private); produces citric acid, gluconates, xanthan gum, and pharmaceutical-grade sodium lactate from corn and wheat starch fermentation. Jungbunzlauer operates fermentation plants in Austria (Pernhofen), Germany (Ladenburg), and Canada. Pharmaceutical sodium lactate from Jungbunzlauer meets USP/EP monograph requirements for injectable use in Lactated Ringer's solution. Jungbunzlauer was founded in 1867 in Basel — the same Swiss city as Novartis, Roche, and Syngenta headquarters — making it one of the Swiss chemical industry's quieter but older specialty chemical producers.
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input Jungbunzlauer Suisse AG supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Jungbunzlauer Suisse AG makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Citric Acid
45%Pharmaceutical Lactates & Gluconates
25%Xanthan Gum & Specialty Biopolymers
20%Specialty Fermentation Products
10%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Did you know2023
Jungbunzlauer produces citric acid for Coca-Cola and PepsiCo beverage formulations (food and beverage supply chain), pharmaceutical sodium lactate for hospital Lactated Ringer's IV solutions (healthcare supply chain), calcium gluconate for injectable cardiac emergency medications (emergency medicine supply chain), and xanthan gum for food thickening (food texture supply chain) -- from the same Austrian and German fermentation plants. A fermentation capacity constraint at Pernhofen, Austria (caused by a raw material shortage, facility incident, or Austrian regulatory action) would simultaneously affect beverage citric acid supply, IV solution sodium lactate supply, cardiac medication calcium gluconate supply, and food-grade xanthan gum supply. Beverage companies, hospital pharmacies, emergency medicine departments, and food manufacturers share Jungbunzlauer as a common fermentation supplier without any cross-sector supply chain monitoring of their shared exposure.
Jungbunzlauer Suisse AG ↗Origin2023
Jungbunzlauer was founded in 1867 in Basel, Switzerland -- the same year the Swiss Federal Constitution was adopted and three years after Henri Dunant's Geneva Convention. Basel in the late 19th century was becoming one of the world's leading chemical cities: Geigy (1758), Ciba (1859), and Sandoz (1886) were already operating there; the future merger of these companies into Novartis and the growth of Roche (founded 1896) would make Basel's Rhenish chemical corridor one of the world's most significant. Jungbunzlauer, originally producing citric acid through mold fermentation of sugar (predating the industrial Aspergillus niger fermentation process commercialized by Pfizer in the 1920s), grew quietly alongside Basel's pharmaceutical giants while remaining privately held and focused on fermentation chemistry. Today, Jungbunzlauer is one of the world's largest citric acid producers and a significant pharmaceutical sodium lactate supplier -- one of the older names in Basel's specialty chemical ecosystem that never listed publicly despite operating for 157 years. Its pharmaceutical products (injectable sodium lactate, calcium gluconate) go into hospital IV solutions; its food products (citric acid, xanthan gum) go into soft drinks and salad dressings -- from the same Basel-headquartered private company.
Jungbunzlauer Suisse AG ↗